Research Article: Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy–Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling
Introduction:
The National Comprehensive Cancer Network (NCCN) and European Society for Medical Oncology (ESMO) guidelines recommend platinum-based therapy (PBT) for first-line (L) treatment of patients with advanced urothelial carcinoma (aUC) followed by maintenance avelumab in patients without disease progression after L PBT. , However, differences in overall survival (OS) endpoint assessment, inclusion criteria, and trial populations between the JAVELIN Bladder trial (JAVELIN), which investigated maintenance avelumab, and a…
Read more